Comparison of liver SUV using unenhanced CT versus contrast-enhanced CT for attenuation correction in 18F-FDG PET/CT

Nuclear Medicine Communications

Volumn 35, Issue 5, 2014, Pages 472-477

  Ter Voert, Edwin E G W ^a   Van Laarhoven, Hanneke W M ^a,b   Kok, Peter J M ^a   Oyen, Wim J G ^a   Visser, Eric P ^a   De Geus Oei, Lioe Fee ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Attenuation correction; Contrast enhanced CT; liver; PET

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; IMATINIB; IOVERSOL; PACLITAXEL; SUNITINIB; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG LIVER LEVEL; DRUG MEGADOSE; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GLIOSARCOMA; HUMAN; INTERMETHOD COMPARISON; LOW DRUG DOSE; MALE; PET-CT SCANNER; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; RADIATION DOSE; RADIOLOGICAL PARAMETERS; STANDARDIZED UPTAKE VALUE; TESTIS CANCER; UTERINE CERVIX CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; IMAGE PROCESSING; LIVER; METABOLISM; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RADIOGRAPHY; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84897573799     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000086     Document Type: Article

References (10)

1. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41:1369-1379
2. Hicks R, Lau E, Binns D. Hybrid imaging is the future of molecular imaging. Biomed Imaging Interv J 2007; 3:e49
3. Kamel E, Hany TF, Burger C, Treyer V, Lonn AHR, von Schulthess GK, et al. CTvs 68Ge attenuation correction in a combined PET/CT system: Evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 2002; 29:346-350
4. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009; 50:122S-150S.
5. Boellaard R, O'Doherty MJ,WeberWA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: Version 1.0. Eur J Nucl Med Mol Imaging 2010; 37:181-200
6. Goerres GW, Burger C, Schwitter MR, Heidelberg T-NH, Seifert B, von Schulthess GK. PET/CT of the abdomen: Optimizing the patient breathing pattern. Eur Radiol 2003; 13:734-739
7. Mawlawi O, Erasmus JJ, Munden RF, Pan T, Knight AE, Macapinlac HA, et al. Quantifying the effect of IV contrast media on integrated PET/CT: Clinical evaluation. Am J Roentgenol 2006; 186:308-319
8. Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, et al. Application of intravenous contrast in PET/CT: Does it really introduce significant attenuation correction error? J Nucl Med 2005; 46:283-291
9. Heijmen L, de Geus-Oei L-F, de Wilt J, Visvikis D, Hatt M, Visser E, et al. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer. Eur J Nucl Med Mol Imaging 2012;1-10
10. Velasquez LM, Boellaard R, Kollia G, Hayes W, Hoekstra OS, Lammertsma AA, et al. Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. J Nucl Med 2009; 50:1646-1654.